SCHEDULE 13G: Polar Asset Management Discloses 5.7% Stake in Drugs Made In America Acquisition Corp
Beneficial Ownership Disclosure
Polar Asset Management Partners Inc. has reported a 5.7% beneficial ownership stake in Drugs Made In America Acquisition Corp, holding 1.9 million ordinary shares.
Summary
- Polar Asset Management Partners Inc., an investment adviser based in Ontario, Canada, has filed a Schedule 13G disclosing a beneficial ownership stake in Drugs Made In America Acquisition Corp.
- The firm holds 1,900,000 ordinary shares, representing 5.7% of the issuer's class of securities.
- The shares are held with sole voting and sole dispositive power by Polar Asset Management Partners Inc. on behalf of Polar Multi-Strategy Master Fund.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of an ownership stake without performance or strategic details.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/15/2025 | Date of Schedule 13G filing signature |
Keywords
Drugs Made In America Acquisition Corp, Polar Asset Management Partners Inc., Schedule 13G, Beneficial Ownership, Investment Adviser, Ordinary Shares, SEC Filing, G2847J104
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.